We've found
8,085
archived clinical trials in
Cervical Cancer
We've found
8,085
archived clinical trials in
Cervical Cancer
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Updated: 12/31/1969
A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
